LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 185

Search options

  1. Article ; Online: Can Risk Stratification Scores Improve Selection Of Patients Who Need Primary Prevention Implantable Cardioverter-Defibrillators Or Should We Just Follow The Rules?

    Naccarelli, Gerald V

    The American journal of cardiology

    2023  Volume 211, Page(s) 355–357

    MeSH term(s) Humans ; Defibrillators, Implantable ; Patient Selection ; Risk Factors ; Risk Assessment ; Primary Prevention ; Death, Sudden, Cardiac/prevention & control
    Language English
    Publishing date 2023-11-10
    Publishing country United States
    Document type Editorial
    ZDB-ID 80014-4
    ISSN 1879-1913 ; 0002-9149
    ISSN (online) 1879-1913
    ISSN 0002-9149
    DOI 10.1016/j.amjcard.2023.11.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Direct Oral Anticoagulants: Patients Benefit When Prescribers Get the Message.

    Naccarelli, Gerald V

    The American journal of cardiology

    2023  Volume 206, Page(s) 365–367

    MeSH term(s) Humans ; Anticoagulants/therapeutic use ; Warfarin/therapeutic use ; Atrial Fibrillation/drug therapy ; Stroke/drug therapy ; Administration, Oral
    Chemical Substances Anticoagulants ; Warfarin (5Q7ZVV76EI)
    Language English
    Publishing date 2023-09-06
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 80014-4
    ISSN 1879-1913 ; 0002-9149
    ISSN (online) 1879-1913
    ISSN 0002-9149
    DOI 10.1016/j.amjcard.2023.08.089
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Are Class IC Antiarrhythmic Agents Safe in Atrial Fibrillation Patients With Nonobstructive Coronary Artery Disease?

    Naccarelli, Gerald V

    JACC. Clinical electrophysiology

    2023  Volume 9, Issue 7 Pt 2, Page(s) 1181–1183

    MeSH term(s) Humans ; Atrial Fibrillation/complications ; Atrial Fibrillation/drug therapy ; Coronary Artery Disease/complications ; Coronary Artery Disease/drug therapy ; Anti-Arrhythmia Agents/adverse effects
    Chemical Substances Anti-Arrhythmia Agents
    Language English
    Publishing date 2023-03-22
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 2846739-5
    ISSN 2405-5018 ; 2405-500X ; 2405-500X
    ISSN (online) 2405-5018 ; 2405-500X
    ISSN 2405-500X
    DOI 10.1016/j.jacep.2023.01.034
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Antiarrhythmic Drug Therapy: Where Do We Go From Here?

    Kowey, Peter R / Naccarelli, Gerald V

    Circulation

    2024  Volume 149, Issue 11, Page(s) 801–803

    MeSH term(s) Humans ; Anti-Arrhythmia Agents/adverse effects ; Atrial Fibrillation/drug therapy
    Chemical Substances Anti-Arrhythmia Agents
    Language English
    Publishing date 2024-03-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80099-5
    ISSN 1524-4539 ; 0009-7322 ; 0069-4193 ; 0065-8499
    ISSN (online) 1524-4539
    ISSN 0009-7322 ; 0069-4193 ; 0065-8499
    DOI 10.1161/CIRCULATIONAHA.123.066989
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Aggressive treatment of atrial fibrillation in hypertrophic cardiomyopathy patients improve quality of life.

    Naccarelli, Gerald V / Popjes, Eric D

    Journal of cardiovascular electrophysiology

    2024  Volume 35, Issue 4, Page(s) 664–666

    MeSH term(s) Humans ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/surgery ; Quality of Life ; Anti-Arrhythmia Agents/therapeutic use ; Cardiomyopathy, Hypertrophic/complications ; Cardiomyopathy, Hypertrophic/diagnosis ; Cardiomyopathy, Hypertrophic/therapy
    Chemical Substances Anti-Arrhythmia Agents
    Language English
    Publishing date 2024-02-08
    Publishing country United States
    Document type Editorial
    ZDB-ID 1025989-2
    ISSN 1540-8167 ; 1045-3873
    ISSN (online) 1540-8167
    ISSN 1045-3873
    DOI 10.1111/jce.16210
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Should Patients with Subclinical Atrial Fibrillation Receive Anticoagulation?

    Reiffel, James A / Kowey, Peter R / Naccarelli, Gerald V

    The American journal of medicine

    2024  

    Language English
    Publishing date 2024-01-26
    Publishing country United States
    Document type Editorial
    ZDB-ID 80015-6
    ISSN 1555-7162 ; 1873-2178 ; 0002-9343 ; 1548-2766
    ISSN (online) 1555-7162 ; 1873-2178
    ISSN 0002-9343 ; 1548-2766
    DOI 10.1016/j.amjmed.2024.01.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Direct Oral Anticoagulant Dosing: Truth or Consequences.

    Naccarelli, Gerald V

    Journal of the American College of Cardiology

    2020  Volume 76, Issue 12, Page(s) 1437–1439

    MeSH term(s) Anticoagulants/adverse effects ; Atrial Fibrillation ; Humans ; Warfarin
    Chemical Substances Anticoagulants ; Warfarin (5Q7ZVV76EI)
    Language English
    Publishing date 2020-09-17
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 605507-2
    ISSN 1558-3597 ; 0735-1097
    ISSN (online) 1558-3597
    ISSN 0735-1097
    DOI 10.1016/j.jacc.2020.08.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Should we limit antiarrhythmic drug choice in patients with left ventricular hypertrophy?

    Naccarelli, Gerald V / Kowey, Peter R

    Journal of cardiovascular electrophysiology

    2022  Volume 34, Issue 2, Page(s) 453–454

    MeSH term(s) Humans ; Anti-Arrhythmia Agents/adverse effects ; Hypertrophy, Left Ventricular/drug therapy ; Amiodarone ; Atrial Fibrillation
    Chemical Substances Anti-Arrhythmia Agents ; Amiodarone (N3RQ532IUT)
    Language English
    Publishing date 2022-11-09
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 1025989-2
    ISSN 1540-8167 ; 1045-3873
    ISSN (online) 1540-8167
    ISSN 1045-3873
    DOI 10.1111/jce.15732
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Antiarrhythmic Drugs for Atrial Fibrillation in the Real World: Trick or Treat.

    Naccarelli, Gerald V

    JACC. Clinical electrophysiology

    2019  Volume 5, Issue 2, Page(s) 242–244

    MeSH term(s) Anti-Arrhythmia Agents ; Atrial Fibrillation ; Electric Countershock ; Humans
    Chemical Substances Anti-Arrhythmia Agents
    Language English
    Publishing date 2019-02-20
    Publishing country United States
    Document type Editorial ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 2846739-5
    ISSN 2405-5018 ; 2405-500X ; 2405-500X
    ISSN (online) 2405-5018 ; 2405-500X
    ISSN 2405-500X
    DOI 10.1016/j.jacep.2018.10.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Understanding Antiarrhythmic Drug Efficacy for the Clinical Practitioner: There Is More than Meets the Eye.

    Reiffel, James A / Naccarelli, Gerald V

    The American journal of medicine

    2022  Volume 135, Issue 7, Page(s) 822–827

    Abstract: Determining if a medication is effective should be easy: Either the condition is or is not improved. However, the truth is often more complex than that, including in the antiarrhythmic drug (AAD) management of atrial fibrillation. In clinical trials, AAD ...

    Abstract Determining if a medication is effective should be easy: Either the condition is or is not improved. However, the truth is often more complex than that, including in the antiarrhythmic drug (AAD) management of atrial fibrillation. In clinical trials, AAD efficacy is usually determined by the time to first atrial fibrillation recurrence. Another AAD efficacy endpoint, in patients with cardiac implantable electrical devices, is a reduction of atrial fibrillation burden. Other cardiovascular outcomes have included hospitalization, heart failure, and cardiovascular or total mortality. In clinical practice AADs, for atrial fibrillation, are prescribed to reduce symptoms/improve quality of life, which usually correlate with reduced atrial fibrillation frequency, duration, and beneficial hemodynamic effects in certain patient subgroups. Time to first recurrence is not a reliable predictor of clinical efficacy endpoints in practice. This article presents a review for the practitioner of AAD efficacy endpoints in clinical trials versus those in clinical practice and why such differences are present.
    MeSH term(s) Anti-Arrhythmia Agents/therapeutic use ; Atrial Fibrillation/drug therapy ; Catheter Ablation ; Heart Failure/drug therapy ; Humans ; Quality of Life ; Treatment Outcome
    Chemical Substances Anti-Arrhythmia Agents
    Language English
    Publishing date 2022-03-14
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 80015-6
    ISSN 1555-7162 ; 1873-2178 ; 0002-9343 ; 1548-2766
    ISSN (online) 1555-7162 ; 1873-2178
    ISSN 0002-9343 ; 1548-2766
    DOI 10.1016/j.amjmed.2022.02.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top